.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Cerilliant
Citi
Teva
McKinsey
Boehringer Ingelheim
US Department of Justice
Medtronic
Mallinckrodt
Harvard Business School

Generated: June 29, 2017

DrugPatentWatch Database Preview

VALPIN 50 Drug Profile

« Back to Dashboard

Which patents cover Valpin 50, and when can generic versions of Valpin 50 launch?

Valpin 50 is a drug marketed by Endo Pharms and is included in one NDA.

The generic ingredient in VALPIN 50 is anisotropine methylbromide. There is one drug master file entry for this compound. Additional details are available on the anisotropine methylbromide profile page.

Summary for Tradename: VALPIN 50

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list11
Patent Applications: see list262
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VALPIN 50 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Pharms
VALPIN 50
anisotropine methylbromide
TABLET;ORAL013428-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
McKinsey
Citi
Express Scripts
McKesson
Medtronic
US Department of Justice
Johnson and Johnson
Teva
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot